World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00050752
Date of registration: 17/12/2002
Primary sponsor: National Cancer Institute (NCI)
Public title: Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
Scientific title: Hereditary Leiomyomatosis Renal Cell Cancer (HLRCC): Identification of the Disease Gene and Characterization of the Predisposition to Renal Cancer
Date of first enrolment: December 2002
Target sample size: 650
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT00050752
Study type:  Observational
Study design:  N/A  
Countries of recruitment
United States
Contacts
Name:   For more information at the NIH Clinical Center contact National Cancer Institute Referral Office
Address: 
Telephone: (888) NCI-1937
Email:
Affiliation: 
Name:   W. Marston Linehan, M.D.
Address: 
Telephone: (301) 496-6353
Email: linehanm@mail.nih.gov
Affiliation: 
Name:   W. Marston Linehan, M.D.
Address: 
Telephone:
Email:
Affiliation:  National Cancer Institute (NCI)
Key inclusion & exclusion criteria

- INCLUSION CRITERIA:

Patients with known or suspected Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
and their family members of any age will be recruited from the dermatology, urology,
oncology, and genetics communities worldwide.

An individual from a family in which one or more family member have:

- Cutaneous leiomyoma and kidney cancer

- Cutaneous leiomyoma and uterine leiomyoma

- Multiple cutaneous leiomyoma

- Kidney cancer and uterine leiomyomata

- Renal tumor histology consistent with HRLRCC including, but not limited to:
Collecting Duct and/or Papillary, Type II

Spouses enrolled primarily for linkage analysis

EXCLUSION CRITERIA:

Persons unable to give informed consent.



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Kidney Neoplasms
Leiomyomatosis
Intervention(s)
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
03-C-0066
030066
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history